Alison Dziarmaga, VP, US Franchise Head of Breast Cancer at AstraZeneca, shared a post on LinkedIn:
“At AstraZeneca’s annual awards ceremony, we celebrated 2025 Oncology achievements that bring us closer to our global ambition: eliminating cancer as a cause of death.
I’m proud of the recognition for our US Breast Cancer team—whose passion, cross-functional collaboration and excellent execution are advancing care for people living with metastatic breast cancer.
It was especially meaningful to receive this award live from the San Antonio Breast Cancer Symposium (SABCS), where we’re sharing new data across stages and subtypes from our breast cancer portfolio. SABCS stands out for how the entire breast cancer community – industry, oncologists, policy makers and patient advocates – all come together to drive progress in research and clinical care.
It’s an incredible time in breast cancer, with so many reasons to be hopeful, and still so much work ahead. We’ll keep driving until the very end!”
More posts about AstraZeneca.